SCHEMBL7898159

SCHEMBL7898159

OC[C@@H]1CC(F)[C@H](n2cnc3c(O)ncnc32)O1.[NaH]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.45
ERBB2 P04626 1/20 0.45
SLC29A1 Q99808 3/20 0.43
ADORA3 P0DMS8 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
ADORA1 P30542 2/20 0.42
DPP4 P27487 1/20 0.42
MEN1 O00255 1/20 0.42
SLC28A1 O00337 1/20 0.42
MAP3K7 O43318 1/20 0.42
SLC28A2 O43868 1/20 0.42
GAPDH P04406 1/20 0.42
MAPK1 P28482 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA2B P29275 1/20 0.42
STAT6 P42226 1/20 0.42
PI4KA P42356 1/20 0.42
KMT2A Q03164 1/20 0.42
PI4K2B Q8TCG2 1/20 0.42
DOT1L Q8TEK3 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL7907737 0.99 EGFR (0.44) EGFRERBB2SLC29A1ADORA3SMN1; SMN2
SCHEMBL342030 0.99 EGFR (0.46) EGFRERBB2SLC29A1ADORA3SMN1; SMN2
SCHEMBL9447631 0.99 EGFR (0.46) EGFRERBB2SLC29A1ADORA3SMN1; SMN2
SCHEMBL3067 0.99 EGFR (0.46) EGFRERBB2SLC29A1ADORA3SMN1; SMN2
SCHEMBL30998177 0.99 EGFR (0.46) EGFRERBB2SLC29A1ADORA3SMN1; SMN2
SCHEMBL969339 0.99 EGFR (0.46) EGFRERBB2SLC29A1ADORA3SMN1; SMN2
Water SCHEMBL8705007 0.98 EGFR (0.45) EGFRERBB2SLC29A1ADORA3SMN1; SMN2
Water SCHEMBL8705010 0.98 EGFR (0.45) EGFRERBB2SLC29A1ADORA3SMN1; SMN2
Water SCHEMBL27310451 0.98 EGFR (0.45) EGFRERBB2SLC29A1ADORA3SMN1; SMN2
SCHEMBL7898163 0.98 EGFR (0.45) EGFRERBB2SLC29A1ADORA3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207650-B1 USEFUL AS INTERMEDIATES OR AS ANTIVIRAL AGENTS BRISTOL-MYERS SQUIBB COMPANY 2001-03-27 US disclosed
EP-0398230-B1 Antiviral, highly water soluble, stable, crystalline salts of 2',3'-dideoxyinoside monohydrate, 2',3'-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate BRISTOL MYERS SQUIBB CO (US) 1998-01-21 EP disclosed